Theranos

2006 Series C Biotechnology Raised $28,500,000
Industry
Biotechnology
Stage
Series C
Raised
$28,500,000

Company Overview

Theranos was a privately-held consumer healthcare technology company that is now arguably the largest biomedical fraud in U.S. history. Its founder, Elizabeth Holmes, was convicted of investor fraud after a series of Wall Street Journal WSJ articles that revealed the tests the company claimed to be doing were actually being carried out by traditional machines purchased from other companies. At its peak, it was valued at $10 billion.

Business Model

E-commerce

Customer Model

B2G, B2B2C

Pitch Deck

Market Opportunity

Discover the market opportunity in the Biotechnology industry. Learn about market size, growth potential, and competitive landscape.

Explore Market Research →

Similar Companies

View pitch decks from other series c companies in the Biotechnology industry.

View Similar Pitch Decks →

Resources & Tips

Pitch Deck Best Practices

Learn how to create an effective pitch deck that resonates with investors.

Read Guide →

Fundraising Strategy

Get insights on fundraising strategies for series c startups.

Learn More →

Find Investors

Connect with investors interested in Biotechnology startups.

Browse Investors →